The 21st Century Cares Act was passed with an overwhelming majority on July 10th, 2015. This bill would increase the funding for both the NIH and FDA and instate a new framework for evaluating patience’s experience with drugs risks and benefits. Not only will the bill help the drug approval process, it also establishes a new national pediatrics research network and will be impacting CRO’s.
This bill will impact the pharmaceutical industry tremendously. Critics of the bill are worried how it will be paid for and how it will bring new cures to the market. Although the payment of the bill is not stated, many are looking forward to see how the bill will help the world.
To read more on Zachary Brennan’s article in outsourcing-pharma, click here.